Global Market Report

Rosacea Treatment Market Report 2020-2030

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

SKU: PHA0589 Category: Tag: Code: PHA0589Pages: 157
Clear
โ† Back to category Drug Discovery Development & Production

Description

Our 150+ page report provides 62 tables, 36 charts and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Rosacea Treatment market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the global market and submarkets
Along with revenue prediction for the overall world market, there are 2 segmentations of the Rosacea Treatment market, with forecasts for 7 Drug class treatment, 2 Mode of administration, each forecasted at a global and regional level.

Global Rosacea Treatment Market by Drug Class
– Antibiotics
– Alpha agonists
– Retinoids
– Corticosteroids
– Immunosuppressants
– Antihypertensive Agents
– Other Drug Class

Global Rosacea Treatment Market by Mode of Administration
– Topical
– Oral

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

– North America:
– US
– Canada

– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia
– ASEAN
– Rest of Asia-Pacific

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– MEA:
– UAE
– South Africa
– Saudi Arabia
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Rosacea Treatment Market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., UK, Germany, Japan, India and China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Rosacea Treatment will surpass $2 bn in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Rosacea Treatment Market report helps you

In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 2 segmentations of the Rosacea Treatment market, with forecasts for 7 Drug class treatment, 2 Mode of administration, each forecasted at a global and regional level,discover the industry’s prospects, finding the most lucrative places for investments and revenues
– Revenue forecasts to 2030 for 5 regional and 18 key national markets , See forecasts for the Rosacea Treatment market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, UAE, South Africa and Saudi Arabia.
– Stimulates and restrains companies and the market
– Prospects for established firms and those seeking to enter the market, including company profiles for 16 of the major companies involved in the Rosacea Treatment market
– Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain study is for everybody needing commercial analyses for the Rosacea Treatment market and leading companies. You will find data, trends and predictions.

Get our report today The Rosacea Treatment Market Forecast 2020-2030: Revenue Prospects by Drug Class Treatment (Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, Other Drug Classes), Mode of administration (Topical, Oral), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1 Global Rosacea Treatment Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Includes
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction
2.1 Objectives of the Study
2.2 Market Definition
2.3 Market Scope
2.4 Markets Covered
2.5 Years Considered for the Study
2.6 Limitations
2.7 Currency

3. Industry Insights
3.1 Market Drivers
3.1.1 Advanced formulations of drugs
3.1.2 Shift towards combination therapies
3.1.3 Increase in disease prevalence
3.1.4 Sudden rise in the availability of generic medicines for rosacea
3.1.5 Rising geriatric population
3.2 Market Restraints
3.2.1 Generic penetration
3.2.2 Off-label usage of drugs
3.3 Market Opportunities
3.3.1 Growing government expenditure towards better healthcare facilities in Asia Pacific region
3.3.2 Strong pipeline drugs
3.4 Value chain analysis
3.5 SWOT analysis (qualitative insights)
3.5.1 Sources of strengths which could be leveraged
3.5.2 Weaknesses to overcome & offset
3.5.3 Opportunities to capitalize upon
3.5.4 Threats to mitigate
3.6 PEST analysis (qualitative insights)
3.6.1 Political factors
3.6.1.1 Description and overview of political factors
3.6.1.2 Definition and identification of relevant political factors
3.6.1.3 Political concerns
3.6.1.4 Reforms and Regulations
3.6.1.5 Political stability
3.6.2 Economic factors
3.6.2.1 Barriers
3.6.2.2 Business models
3.6.2.3 Definition and identification of economic factors
3.6.2.4 Description and overview of economic factors
3.6.2.5 Economic concerns
3.6.2.6 Economic value
3.6.2.7 Resource efficiency
3.6.3 Social factors
3.6.3.1 Description and overview of social factors
3.6.3.2 Definition and identification of social factors
3.6.3.3 Social concerns
3.6.3.4 Knowledge and skills
3.6.4 Technological factors
3.6.4.1 Description and overview of technological factors
3.6.4.2 Definition and identification of technological factors
3.6.4.3 Technological concerns
3.7 Porters Five Forces Model (qualitative insights)
3.7.1 Industrial competitors
3.7.1.1 Barriers to exit
3.7.1.2 Diversity of competitors
3.7.1.3 Industry concentration
3.7.1.4 Industry growth
3.7.1.5 Number of competitors
3.7.1.6 Quality differences
3.7.1.7 Switching costs
3.7.2 Threat of Substitutes
3.7.2.1 Buyer propensity to substitute
3.7.2.2 Number of substitute products available
3.7.2.3 Perceived level of product differentiation
3.7.2.4 Relative price performance of substitute
3.7.3 Bargaining Power of Buyers
3.7.3.1 Ability to backward integrate
3.7.3.2 Brand identity impact on quality/performance
3.7.3.3 Buyer concentration versus firm concentration
3.7.3.4 Buyer information
3.7.3.5 Buyer profits
3.7.3.6 Buyer switching costs relative to firm switching costs
3.7.4 Bargaining Power of Suppliers
3.7.4.1 Focal company's ability to substitute
3.7.4.2 Number and size of suppliers
3.7.4.3 Uniqueness of each supplier's product
3.7.5 Threat of New Entrants
3.7.5.1 Access to distribution channel
3.7.5.2 Barriers to entry
3.7.5.3 Brand loyalty
3.7.5.4 Capital requirements
3.7.5.5 Economies of scale
3.7.5.6 Government policies
3.7.5.7 Switching costs

4. Global Rosacea Treatment market - By Drug Class
4.1 Antibiotics
4.1.1 Market size and forecast, 2020-2030 (USD Million)
4.2 Alpha agonists
4.2.1 Market size and forecast, 2020-2030 (USD Million)
4.3 Retinoids
4.3.1 Market size and forecast, 2020-2030 (USD Million)
4.4 Corticosteroids
4.4.1 Market size and forecast, 2020-2030 (USD Million)
4.5 Immunosuppressants
4.5.1 Market size and forecast, 2020-2030 (USD Million)
4.6 Antihypertensive Agents
4.6.1 Market size and forecast, 2020-2030 (USD Million)
4.7 Other drug class treatments
4.7.1 Market size and forecast, 2020-2030 (USD Million)

5. Global Rosacea Treatment market - By Mode of administration
5.1 Topical
5.1.1 Market size and forecast, 2020-2030 (USD Million)
5.2 Oral
5.2.1 Market size and forecast, 2020-2030 (USD Million)

6. By Region
6.1 Introduction
6.2 North America Rosacea Treatment Market, 2020-2030 (USD Million)
6.2.1 U.S.
6.2.1.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.2.1.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.2.2 Canada
6.2.2.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.2.2.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3 Europe Rosacea Treatment Market, 2020-2030 (USD Million)
6.3.1 Germany
6.3.1.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.1.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.2 France
6.3.2.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.2.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.3 UK
6.3.3.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.3.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.4 Italy
6.3.4.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.4.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.5 Spain
6.3.5.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.5.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.6 Russia
6.3.6.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.6.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.3.7 Rest of Europe
6.3.7.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.3.7.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4 Asia-Pacific Rosacea Treatment Market, 2020-2030 (USD Million)
6.4.1 Japan
6.4.1.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.1.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4.2 China
6.4.2.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.2.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4.3 India
6.4.3.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.3.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4.4 Australia
6.4.4.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.4.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4.5 ASEAN
6.4.5.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.5.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.4.6 Rest of APAC
6.4.6.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.4.6.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.5 Latin America Rosacea Treatment Market, 2020-2030 (USD Million)
6.5.1 Brazil
6.5.1.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.5.1.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.5.2 Mexico
6.5.2.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.5.2.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.5.3 Rest of Latin America
6.5.3.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.5.3.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.6 Middle East Rosacea Treatment Market, 2020-2030 (USD Million)
6.6.1 UAE
6.6.1.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.6.1.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.6.2 Saudi Arabia
6.6.2.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.6.2.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.6.3 South Africa
6.6.3.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.6.3.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)
6.6.4 RoMEA
6.6.4.1 Market Size & Forecast, By Drug class treatment, 2020-2030 (USD Million)
6.6.4.2 Market Size & Forecast, By Mode of administration, 2020-2030 (USD Million)

7. Competitive Landscape
7.1 Competitive environment
7.2 New product development
7.3 Merger & acquisitions
7.4 Strategic framework

8. Leading Companies
8.1 Allergan plc
8.1.1 Company Overview
8.1.2 Product Offerings
8.1.3 Financial Performance (2016-2018)
8.1.4 Recent Initiatives
8.2 Bausch Health Companies Inc.
8.2.1 Company Overview
8.2.2 Product Offerings
8.2.3 Financial Performance (2016-2018)
8.2.4 Recent Initiatives
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Product Offerings
8.3.3 Financial Performance (2016-2018)
8.3.4 Recent Initiatives
8.4 Foamix Pharmaceuticals Ltd.
8.4.1 Company Overview
8.4.2 Product Offerings
8.4.3 Financial Performance (2016-2018)
8.4.4 Recent Initiatives
8.5 Janssen Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Product Offerings
8.5.3 Financial Performance (2016-2018)
8.5.4 Recent Initiatives
8.6 Mylan N.V.
8.6.1 Company Overview
8.6.2 Product Offerings
8.6.3 Financial Performance (2016-2018)
8.6.4 Recent Initiatives
8.7 Nestlรฉ Skin Health (Galderma S.A.)
8.7.1 Company Overview
8.7.2 Product Offerings
8.7.3 Financial Performance (2016-2018)
8.7.4 Recent Initiatives
8.8 Pfizer Inc.
8.8.1 Company Overview
8.8.2 Product Offerings
8.8.3 Financial Performance (2016-2018)
8.8.4 Recent Initiatives
8.9 Sol-Gel Technologies
8.9.1 Company Overview
8.9.2 Product Offerings
8.9.3 Financial Performance (2016-2018)
8.9.4 Recent Initiatives
8.10 SONOMA PHARMACEUTICALS, INC.
8.10.1 Company Overview
8.10.2 Product Offerings
8.10.3 Financial Performance (2016-2018)
8.10.4 Recent Initiatives
8.11 Teva Pharmaceuticals Company
8.11.1 Company Overview
8.11.2 Product Offerings
8.11.3 Financial Performance (2016-2018)
8.11.4 Recent Initiatives
8.12 Aclaris Therapeutics
8.12.1 Company Overview
8.12.2 Product Offerings
8.12.3 Financial Performance (2016-2018)
8.12.4 Recent Initiatives
8.13 Amorepacific Corporation
8.13.1 Company Overview
8.13.2 Product Offerings
8.13.3 Financial Performance (2016-2018)
8.13.4 Recent Initiatives
8.14 Hovione FarmaCiencia SA
8.14.1 Company Overview
8.14.2 Product Offerings
8.14.3 Financial Performance (2016-2018)
8.14.4 Recent Initiatives
8.15 Leo Pharma Inc.
8.15.1 Company Overview
8.15.2 Product Offerings
8.15.3 Financial Performance (2016-2018)
8.15.4 Recent Initiatives
8.16 PRUGEN PHARMACEUTICALS
8.16.1 Company Overview
8.16.2 Product Offerings
8.16.3 Financial Performance (2016-2018)
8.16.4 Recent Initiatives

9. Appendix
9.1 Insights of Industry Experts
9.2 Related Reports
9.3 Author Details
9.4 Available Customizations

LIST OF TABLES
Table 1 Global Rosacea Treatment Market Size, By Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 4 North America: Rosacea Treatment Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 5 North America: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 7 US: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 8 US: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 9 Canada: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 10 Canada: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 11 Europe: Rosacea Treatment Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 12 Europe: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 13 Europe: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 14 Germany: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 15 Germany: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 16 France: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 17 France: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 18 UK: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 19 UK: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 20 Italy: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 21 Italy: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 22 Spain: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 23 Spain: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 24 Russia: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 25 Russia: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 26 Rest of Europe: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 27 Rest of Europe: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 28 Asia-Pacific: Rosacea Treatment Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 29 Asia-Pacific: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 30 Asia-Pacific: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 31 Japan: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 32 Japan: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 33 China: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 34 China: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 35 India: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 36 India: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 37 Australia: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 38 Australia: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 39 ASEAN: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 40 ASEAN: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 41 Rest of APAC: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 42 Rest of APAC: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 43 Latin America: Rosacea Treatment Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 44 Latin America: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 45 Latin America: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 46 Brazil: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 47 Brazil: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 48 Mexico: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 49 Mexico: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 50 Rest of Latin America: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 51 Rest of Latin America: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 52 MEA: Rosacea Treatment Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 53 MEA: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 54 MEA: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 55 UAE: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 56 UAE: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 57 Saudi Arabia: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 58 Saudi Arabia: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 59 South Africa: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 60 South Africa: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)
Table 61 Rest of MEA: Rosacea Treatment Market Size, By Drug class treatment, 2020-2030 (USD Mn, CAGR%)
Table 62 Rest of MEA: Rosacea Treatment Market Size, By Mode of administration, 2020-2030 (USD Mn, CAGR%)

LIST OF FIGURES
Figure 1 Global Rosacea Treatment Market Segmentation
Figure 2 Global Rosacea Treatment Market: Market Dynamics
Figure 3 Global Rosacea Treatment Market Porter's analysis
Figure 4 Global Rosacea Treatment Market PEST analysis
Figure 5 Drivers, Restraints, Opportunities, and Challenges in the Global Rosacea Treatment Market
Figure 6 Global Rosacea Treatment Market, By Drug class treatment, 2020-2030 (USD Mn)
Figure 7 Global Rosacea Treatment Market, By Mode of administration, 2020-2030 (USD Mn)
Figure 8 Global Rosacea Treatment Market, By Region, 2018 & 2030 (%)
Figure 9 North America Rosacea Treatment Market, By Country, 2018 & 2030 (%)
Figure 10 U.S. Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 11 Canada Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 12 Europe Rosacea Treatment Market, By Country, 2018 & 2030 (%)
Figure 13 Germany Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 14 UK Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 15 France Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 16 Italy Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 17 Spain Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 18 Russia Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 19 Rest of Europe Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 20 APAC Rosacea Treatment Market, By Country, 2018 & 2030 (%)
Figure 21 Japan Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 22 China Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 23 Australia Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 24 ASEAN Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 25 Rest of APAC Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 26 Latin America Rosacea Treatment Market, By Country, 2018 & 2030 (%)
Figure 27 Brazil Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 28 Mexico Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 29 Rest of Latin America Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 30 MEA Rosacea Treatment Market, By Country, 2018 & 2030 (%)
Figure 31 UAE Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 32 Saudi Arabia Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 33 South Africa Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 34 Rest of MEA Rosacea Treatment Market, 2020-2030 (USD Mn)
Figure 35 Company Share Analysis, 2018
Figure 36 Recent Developments, 2016-2018
Figure 37 Global Rosacea Treatment Market Concentration Rate

Allergan plc
Bausch Health Companies Inc.
Bayer AG
Foamix Pharmaceuticals Ltd.
Janssen Pharmaceuticals, Inc.
Mylan N.V.
Nestlรฉ Skin Health (Galderma S.A.)
Pfizer Inc.
Sol-Gel Technologies
SONOMA PHARMACEUTICALS, INC.
Teva Pharmaceuticals Company
Aclaris Therapeutics
Amorepacific Corporation
Hovione FarmaCiencia SA
Leo Pharma Inc.
PRUGEN PHARMACEUTICALS